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Electrophysiological remodeling of cardiac potassium ion channels is important in the pro-
gression of heart failure. A reduction of the transient outward potassium current (I to) in
mammalian heart failure is consistent with a reduced expression of potassium channel
interacting protein 2 (KChIP2, a KV4 subunit). Approaches have been made to investigate
the role of KChIP2 in shaping cardiac I to, including the use of transgenic KChIP2 deﬁcient
mice and viral overexpression of KChIP2.The interplay between I to and myocardial calcium
handling is pivotal in the development of heart failure, and is further strengthened by the
dual role of KChIP2 as a functional subunit on both KV4 and CaV1.2. Moreover, the potential
arrhythmogenic consequence of reduced I to may contribute to the high relative incidence
of sudden death in the early phases of human heart failure. With this review, we offer an
overview of the insights into the physiological and pathological roles of KChIP2 and we dis-
cuss the limitations of translating the molecular basis of electrophysiological remodeling
from animal models of heart failure to the clinical setting.
Keywords: potassium, ion channels, heart failure, ventricular arrhythmia, knockout mice, action potential,
repolarization, sudden death
INTRODUCTION
The normal pumping action of the mammalian heart is critically
dependent on the cardiac electrophysiological function. Within
a heartbeat, the single cardiac cell generates an action potential
in consequence of sequential depolarizing and repolarizing cur-
rents. The exact function of the multitude of ion channels and
other transporters of electrical charges determines the morphol-
ogy of the action potential. Owing to diversities in properties
and expression proﬁles of ion channels in different regions in
the heart, in different species and in different physiological and
pathological settings, the action potential waveform is highly vari-
able (Carmeliet, 1999;Nerbonne andKass, 2005;Nattel et al., 2007;
Ter Keurs and Boyden, 2007).
The human action potential has a spike-and-dome morphol-
ogy, with a rapid early repolarizing phase or notch that reﬂects
the transient outward potassium current, I to. The magnitude of
the notch determines the membrane potential for the plateau
phase of the action potential, and thus establishes the driving
force for Ca2+ entry through the L-type Ca2+ channel triggering
calcium-induced calcium release and contraction of the myocyte
(Greenstein et al., 2000; Sah et al., 2003). In rodents, I to is the
major repolarizing force abbreviating the action potential consid-
erably in adaptation to the fast heart rates. Reduced I to amplitude
in non-rodent mammals is associated with desynchronized Ca2+
release from intracellular stores (Harris et al., 2005; Wasserstrom
et al., 2009) and suboptimal cardiac performance secondary to
uncoordinated calcium-induced calcium release and contraction
(Sah et al., 2002, 2003; Cordeiro et al., 2004).
The landmark ﬁnding of reduced I to in heart failure (Beuck-
elmann et al., 1993) spurred an intense interest into function and
regulation of this current. An et al. (2000) reported how I to was
modulated by K+-channel interacting proteins (KChIPs). Since
the initial characterization of KChIPs, several additional functions
of KChIPs have been described, including tuning of several ionic
currents and gene-transcription regulation (Buxbaum, 2004). In
the present review,we outline the basic molecular biology and car-
diac electrophysiology of KChIP2 and integrate these ﬁndings in a
discussion of the role of KChIP2 in cardiac plasticity, hypertrophic
remodeling, arrhythmia, and failure.
KChIP STRUCTURE AND EXPRESSION
The KChIPs belong to the family of small cytosolic calcium-
binding proteins and consists of four different KChIP isoforms
ranging between 216 and 270 amino acids. They all have a reason-
ably conserved core regionof 185 amino acids and aheterogeneous
N-terminal part (An et al., 2000; Holmqvist et al., 2002). All
KChIPs have calcium-binding EF hands which appear impor-
tant for modulation KV-channels (An et al., 2000; Li et al., 2005)
but not for CaV-channels (Thomsen et al., 2009c). Myristoyla-
tion of KChIP1 (Burgoyne and Weiss, 2001) and palmitoylation
of KChIP2 (Takimoto et al., 2002) play important roles in post-
translational modiﬁcation to improve plasma membrane local-
ization. It is well established that KChIP1–3 functionally increase
peak KV4 current, slow channel inactivation and accelerate recov-
ery from inactivation (An et al., 2000; Lundby et al., 2010); whereas
KChIP4 eliminates inactivation (Holmqvist et al., 2002). Further-
more, KChIP2 has been reported to increase ICa,L (Thomsen et al.,
2009c), and suggested to decrease KV1.5 cell surface expression (Li
et al., 2005) and facilitate INa (Deschenes et al., 2008).
All four KChIP mRNAs are found in the brain; however only
KChIP2 is expressed in the heart (An et al., 2000; Kuo et al., 2001;
Rosati et al., 2001). KChIP expression in cardiac autonomic nerves
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has not been reported. The cardiac KChIP2 gene generates three
protein isoforms of 220, 252, and 270 amino acids via alternative
splicing of exons 2 and 3 (Kuo et al., 2001). Immunocytochem-
istry has localized KChIP2 to the sarcolemma and the nucleus
(Deschenes et al., 2002). Cardiac expression of KChIP2 is absent
in embryonic and neonatal stages; however developmental upreg-
ulation potentially suggests a physiological role for KChIP2 once
a transmural gradient of I to is appearing (Kuo et al., 2001; Plot-
nikov et al., 2004). KChIP2 is expressed heterogeneously across
the canine and human left and right ventricular free wall with
higher concentrations in epicardium compared to endocardium,
whereas no transmural gradient of expression is found for KV4.3
(Rosati et al., 2001, 2003; Calloe et al., 2009b). This ﬁnding has
led to the suggestion that KChIP2 is responsible for the I to gra-
dient; whereas other studies failed to show a transmural KChIP2
protein gradient in canine and human hearts (Deschenes et al.,
2002), arguing against the role of KChIP2 in the generation of the
transmural I to gradient. More recently, studies of the human heart
have shown strong KChIP2 expression in the epicardium based on
both mRNA and protein levels (Gaborit et al., 2007; Soltysinska
et al., 2009). In mice, transmural KV4.2 protein expression par-
allels the I to,f gradient; whereas KV4.3 and KChIP2 protein levels
were uniformly distributed in an early study (Guo et al., 2002).
More recently, laser capture microdissection of the murine LV has
revealed a transmural gradient of both KV4.2 and KChIP2 mRNA
(Teutsch et al., 2007).
KChIP2 AND ION CHANNELS
KV4
KChIP2 is a cytosolic protein when expressed in absence of
KV4; however co-expression of KV4 and KChIP2 leads to co-
localization at the cell surface (An et al., 2000; Bahring et al.,
2001). Biochemically, KChIP2 co-immunoprecipitates with KV4.2
and KV4.3 in mouse ventricular homogenates (Guo et al., 2002).
Crystallographic, electron microscopic and electrophysiological
experiments have shown that KChIPs physically interact with
the distal part of N-terminus of KV4 subunits, forming a cross-
shaped octamer, where two interaction sites on each KV4 sub-
unit are important for KChIP2-mediated channel trafﬁcking and
gating (Bahring et al., 2001; Kim et al., 2004; Pioletti et al.,
2006). KChIP2 decreases the turnover rate of KV4.2 by stabi-
lizing the KChIP2–KV4.2 complex at the cell surface. This sta-
bilization is lost with deletion of the N-terminal part of KV4.2
(Foeger et al., 2010). KChIP2 protein levels are decreased in the
absence of KV4.2, despite unaltered mRNA levels, suggesting post-
translational downregulation of KChIP2 in the absence of the
pore-forming subunit (Guo et al., 2005). In addition, both KV4.2
and KV4.3 mRNA and protein expression are augmented in hearts
from KChIP2−/− mice as well as in cultured neonatal rat car-
diomyocytes overexpressing KChIP2, suggesting regulation of the
pore-forming subunits at gene and protein levels (Thomsen et al.,
2009b; Jin et al., 2010).
The rodent outward potassium currents (Figure 1) involved in
action potential repolarization can broadly be divided into tran-
sient outward (I to) anddelayed rectiﬁer (IK) currents (for a review,
seeNerbonne et al., 2001),which can be further separated into four
components, I to,fast (I to,f , KV4.2/KV4.3+KChIP2), I to,slow (I to,s,
KV1.4), IK,slow1 (IKur, KV1.5), and I k,slow2 (I SS, KV2.1). In order
to dissect these current components, several studies have used
electrophysiology combined with pharmacology on cardiomy-
ocytes of wild-type (WT) or transgenic mice (Himmel et al., 1999;
Brouillette et al., 2004; Brunet et al., 2004; Liu et al., 2011). I to,f
and I to,s both have a fast activation and a fast inactivation and
are under normal conditions very similar, however they can be
distinguished by the rate of recovery from inactivation (Wick-
enden et al., 1999a; Patel and Campbell, 2005). I to,f recovers from
inactivation in the order of milliseconds, whereas I to,s recovers
much slower. In order to inhibit I to,f , an inactivating pre-pulse to
−40mV for 50ms can be applied, which captures I to,f in a closed
state (Brouillette et al., 2004); alternatively Heteropoda toxin can
be used, which selectively blocks KV4 channels in low-micromolar
concentrations (Sanguinetti et al., 1997; DeSimone et al., 2011;
Liu et al., 2011). For evaluating IK,slow1, the sensitivity toward 4-
aminopyridine can be exploited, because IK,slow1 is sensitive in
the micromolar range while I to,f , I to,s, and IK,slow2 are sensitive
in the millimolar range (Guo et al., 1999). Furthermore, in order
to dissect IK,slow2, an inactivating pre-pulse in combination with
micromolar 4-aminopyridine can be used (Brouillette et al., 2004).
Several studies have failed to ﬁnd I to,s in the free wall of the mouse
ventricle and only located it in myocytes from the interventricular
septum (London et al., 1998; Guo et al., 1999).
Electrophysiologically, KChIP2 increases KV4-mediated cur-
rent amplitude and modulates channel gating by slowing the fast
time constant of inactivation at depolarizing potentials and accel-
erating recovery from inactivation (Decher et al., 2001; Deschenes
et al., 2002; Patel et al., 2002). The binding of KChIP2 to KV4 is
calcium-independent; however the effect of KChIP2 on slowing
the fast time constant of inactivation at depolarizing potentials is
dependent on calcium-binding to three of the four EF hands on
KChIP2 (Deschenes et al., 2002; Patel et al., 2002). Interestingly,
when KV4 and KChIP2 are co-expressed in HEK293 the current
inactivation is much slower than the native I to in human and
canine cardiomyocytes (Deschenes et al., 2002), which could be
explained by the presence of additional subunits in the native car-
diac cell. Dipeptidyl-peptidase-like proteins (DPPX) have been
suggested as part of the missing link since a ternary complex
of KV4.3, KChIP2, and DPPX produced currents closely resem-
bling I to,f in mammalian expression systems (Radicke et al., 2005;
Lundby et al., 2010). Additionally, KCNE2–4 have all been impli-
cated in regulation of the KV4-mediated current, suggesting a
diversemacromolecular complex governing I to (Zhang et al., 2001;
Lundby and Olesen, 2006; Lundby et al., 2010).
The development of the KChIP2 deﬁcient mouse provided the
ﬁrst clues to the role of KChIP2 in generating the native I to (Kuo
et al., 2001). Voltage-clamp recordings of KChIP2−/− cardiomy-
ocytes revealed a complete loss of I to,f deﬁned as the portion of
the potassium currents sensitive to an inactivating voltage pre-
pulse to −40mV. Moreover, administration of Heteropoda toxin
to KChIP2−/− cardiomyocytes had no effect on potassium cur-
rent amplitude (Thomsen et al., 2009b). In vivo, the loss of I to,f
translated to an elevated and earlier Jwave of themurineECG,nor-
mal QT intervals and ventricular effective refractory periods, and
susceptibility to pacing-induced polymorphic ventricular tach-
yarrhythmias ( Kuo et al., 2001). Furthermore, we showed that
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FIGURE 1 |Whole-cell voltage-clamp recordings of outward K-currents
recorded in disaggregated left ventricular cardiomyocytes from
wild-type (WT) versus KChIP2−/− mice. Cardiomyocyte isolation and
patch-clamp solutions (37˚C) were made according to (Brouillette et al., 2004)
with minor modiﬁcations. Cadmium (300μM) was added to inhibit L-type
Ca2+ currents. (A) Representative current traces showing that KChIP2−/−
cardiomyocytes lack a fast decaying component of the outward K-current
(solid arrows). (B) Peak current density as a function of test potential,
however, was not signiﬁcantly changed at any voltage (inset, voltage
protocol). (C)The decay of the outward current (0–700ms) was ﬁtted to a
second-order exponential function to obtain time-constants (τ) of inactivation
for positive test potentials. No differences betweenWT and KChIP2−/− were
found for the slow component; however, the fast component of the current
decay was signiﬁcantly slower for KChIP2−/− myocytes, conﬁrming the loss
of a transient component. (D) In order to dissect IK,slow1 from I to,f, the current
sensitive to 100μM 4-AP was determined. The 4-AP sensitive fraction (red)
of the peak current (blue, normalized to 1) was increased in KChIP2−/−
compared toWT, indicating increased IK,slow1. (E) Recovery from inactivation
was addressed by a double-pulse voltage-clamp protocol with varying
interpulse intervals (see inset). Representative current traces fromWT and
KChIP2−/− cardiomyocytes are presented. (F)The mean recovery from
inactivation is illustrated as the peak current during the 0.2-s test pulse
relative to the 1.5-s base pulse. Recovery from inactivation was signiﬁcantly
slowed in KChIP2−/− compared toWT in interpulse intervals between 1 and
4000ms. This is compatible with a larger fraction on the outward potassium
currents attributable to IK,slow relative to I to,f in KChIP2−/− cardiomyocytes.
Data are reported as mean±SEM. Statistical signiﬁcance was evaluated by
ANOVA followed by Newman–Keuls’ post hoc test where appropriate.
*p<0.05. Comparable data have been published previously by Thomsen
et al. (2009b).
transmembrane action potentials were comparable in ventricu-
lar multicellular preparations from KChIP2−/− and WT control
mice paced at 2Hz (Thomsen et al., 2009c), which was presum-
ably secondary to an upregulation of a 4-aminopyridine-sensitive
current that restored peak outward potassium current density in
KChIP2−/− mice (Figure 1). Action potentials recorded from dis-
aggregated right ventricular myocytes from KChIP2−/− mice are
longer than those from WT mice and show reverse rate depen-
dency (Kuo et al., 2001), potentially consequential of the slowed
recovery from inactivation of the remaining outward potassium
currents (Figure 1).
CaV1.2
KChIP2 binds to the N-terminal cytosolic domain of CaV1.2 in
a calcium-independent manner. In heterologous expression sys-
tems, KChIP2 co-expression causes an increase in current medi-
ated by CaV1.2, comparable to the effect of the calcium channel
auxiliary β2 subunit; however KChIP2 was not able to replace the
β2-mediated macromolecular ion channel trafﬁcking to the cell
membrane (Thomsen et al., 2009c). Also this functional modu-
lation was independent of calcium-binding to the EF hands of
KChIP2. Furthermore, the L-type calcium current is signiﬁcantly
smaller in disaggregated cardiomyocytes from KChIP2−/− mice
compared to WT controls (Figure 2). This decrease in current
density was observed in the presence of an intact trafﬁcking path-
way of CaV1.2 and increased transcriptional activity of the β2
subunit (Thomsen et al., 2009a,c). Protein levels of CaV1.2 in the
KChIP2−/− mice are increased, whereas acute gene silencing of
KChIP2 in neonatal rat cardiomyocytes does not affect CaV1.2
protein expression (Deschenes et al., 2008). In addition, in neurons
KChIP3 has been described as part of a macromolecular signaling
complex together with CaV3 and KV4 that confer physiological
calcium modulation of KV4-mediated currents (Anderson et al.,
2010).
NaV1.5
A structural and functional association of I to and INa has been sug-
gested based ondata fromneonatal rat cardiomyocytes (Deschenes
et al., 2008). Genetic silencing of KChIP2 caused a decrease in pro-
tein contents of KV4.2 and KV4.3, presumably due to a trafﬁcking
defect. Interestingly, the authors showed a biochemical association
between KV4 and the auxiliary β1 subunit of the sodium channel,
and went on to demonstrate that KChIP2 silencing also dramati-
cally reduced mRNA and protein levels of NaV1.5 and the sodium
channel β1 subunit to a point where no INa could be recorded
and no action potentials could be elicited (Deschenes et al., 2008).
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FIGURE 2 | L-type Ca2+ current in disaggregated cardiomyocytes from
wild-type (WT) versus KChIP2−/−. ICa,L was recorded at 37˚C in left
ventricular cardiomyocytes as the current fraction sensitive to 300μM
Cd2+, as described by Sah et al. (2002) with minor modiﬁcations. (A)
Representative current traces ofWT and KChIP2−/− (inset, voltage
protocol). (B) Mean peak current densities show a decreased ICa,L in
KChIP2−/− cardiomyocytes. (C) No changes were found in the steady-state
inactivation of ICa,L inWT versus KChIP2−/− cardiomyocytes (inset, voltage
protocol). Data are reported as mean±SEM. Statistical signiﬁcance was
evaluated by ANOVA followed by Newman–Keuls’ post hoc test where
appropriate. *p<0.05. Comparable data have been published previously by
Thomsen et al. (2009c).
Reversibly, co-expression of KChIP2 with NaV1.5 in a mammalian
cell line augmented the sodium current, further substantiating
the functional effect of KChIP2 on INa (Deschenes et al., 2008),
suggesting a close structural and functional link of I to and INa.
These ﬁndings are not reproduced in mice with complete dele-
tion of KChIP2 as they do not show embryonic lethality which
would be expected if INa was reduced to the point the hearts were
inexcitable (Kuo et al., 2001). The KChIP2−/− mice show a small,
but statistically not signiﬁcant, reduction of the upstroke velocity
of action potentials, generally accepted to be an indication of INa
availability (Thomsen et al., 2009b). Furthermore, mRNA levels
for NaV1.5 and β1 are comparable in KChIP2−/− mice and WT
controls (M Thomsen, unpublished data). The reason underlying
the discrepant results is currently unknown, but could include
an unidentiﬁed compensatory adaptation in the embryogenic
development of the knockout mouse to counteract a reduction
in INa.
KV1.5
KV1.5 governs the murine IK,slow and the human atrial-speciﬁc
IKur. In HEK-293 cells, KChIP2 has been reported to reduce
KV1.5 current density without modifying the kinetics of the
current (Li et al., 2005). Immunocytochemistry suggested that
KChIP2 attenuate trafﬁcking of KV1.5 to the plasma membrane
and EF-hand mutations abolished the effect of KChIP2. In the
same study, mouse ventricular KV1.5 and KChIP2 were found to
co-immunoprecipitate (Li et al., 2005). However, co-expression
of KV1.5 with KChIP2 in Xenopus laevis oocytes revealed no
difference in current levels in absence or presence of KChIP2
(Lundby et al., 2010). Additionally, both groups found no effect
of KChIP2 on Kv1.4 currents (Li et al., 2005; Lundby et al.,
2010). In KChIP2−/− mice, KV1.5 mRNA levels were elevated
in KChIP2−/− hearts, suggesting a potential KChIP2-mediated
regulation of Kv1.5 on a transcriptional level.
KChIP2 AND ARRHYTHMIAS
Spontaneous ventricular arrhythmias are rarely seen in mice with
genetic deletion of single potassium currents (Nerbonne et al.,
2001). For example, the KV4.2−/− mouse show complete elimina-
tion of I to,f but normal action potentials and ECG and no sponta-
neous arrhythmia (Guo et al., 2005).On the other hand,prolonged
action potentials andQT intervals were reported in anothermouse
model with total elimination of I to,f (KV4.2-W362F; Barry et al.,
1998). Interestingly, overexpression of a dominant-negative KV4.2
fragment generated a mouse line with reduced I to,f , prolonged
action potentials and hypercontractility that developed into heart
failure within 3months of age (Wickenden et al., 1999b).
TheKChIP2−/− mouse had no spontaneous arrhythmia during
continuousmonitoring of consciousmice; however, it was possible
to induce cardiac tachyarrhythmia by pacing the ventricles (Kuo
et al., 2001). Presently, it is unclear whether the increased suscep-
tibility to pacing-induced arrhythmias is secondary to decreased
repolarizingpotassiumcurrents or decreaseddepolarizing calcium
currents, or a combination of the two.
KChIP2 AND REMODELING
CARDIAC MEMORY
Cardiac memory describe a special form of cardiac plasticity
observed as an altered T wave on the surface ECG (Rosenbaum
et al., 1982). After a period of altered ventricular activation, due to
pacing or arrhythmias, the T wave “remembers” the QRS complex
from the paced or arrhythmic phase. The electrocardiographic T
wave vector during sinus rhythm reﬂects the QRS complex vec-
tor during the preceding period of ventricular activation (Rosen,
2001).
Cardiac memory in dogs is associated with a decrease in I to
and a reduction in KV4.3 mRNA and KChIP2 mRNA and pro-
tein (Yu et al., 1999; Patberg et al., 2003). KV4.2, KChIP2, and
the angiotensin-1 receptor co-localize and immunoprecipitate
together in heart tissue (Doronin et al., 2004). Furthermore, when
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ventricular pacing alters cardiac stretch, angiotensin-II is released
(Sadoshima and Izumo, 1993). Activation of the angiotensin-1
receptor results in an internalization of the macromolecular com-
plex and a decrease in I to density. Secondly, during prolonged
periods of ventricular pacing inducing cardiac memory, cyclic
AMP response element binding protein (CREB) is downregulated
via ubiquitination and proteosomal degradation (Ozgen et al.,
2010). Transcriptional activity of KChIP2 is reduced by low lev-
els of CREB as this fails to associate with cyclic AMP response
elements in the KChIP2-gene promotor region, indirectly caus-
ing a further reduction in I to (Patberg et al., 2005). In summary,
altered ventricular pacing causes a rapid internalization if the KV4
ion channel complex and a reduction in KChIP2 levels further
reducing I to (Rosen and Cohen, 2006). Angiotensin-1 receptor
blockade do not suppress the latter pathway, whereas inhibition
of ICa,L attenuates cardiac memory and I to downregulation, sug-
gesting a role central for calcium handling in the development of
cardiac memory (Plotnikov et al., 2003).
HYPERTROPHY
Hypertrophic enlargement of the ventricles involves complex cel-
lular processes, and is typically divided into concentric hypertro-
phy due to pressure overload and eccentric hypertrophy due to
volume overload. Hypertrophy is associated with growth of the
individual cardiomyocyte which adds sarcomeres to the existing
contractile apparatus, thus responding to the increased demandon
the ventricle. In contrast, the failing heart cannot compensate suf-
ﬁciently, and is impaired in its ability to sustain an adequate blood
ﬂow to the body. Among a plethora of changes, cardiac hypertro-
phy is accompanied by electrophysiological remodeling causing
prolonged action potential durations (Gaughan et al., 1998; Kaab
et al., 1998; Marionneau et al., 2008). Ion channel remodeling in
cardiac hypertrophy and failure has been described recently in
excellent reviews (Nattel et al., 2007; Nass et al., 2008; Aiba and
Tomaselli, 2010). Here, we focus on KChIP2.
Modulating I to affects action potential duration, intracellu-
lar calcium load and contractile force in a complex manner. In
larger mammals, pharmacological activation of I to lead to pro-
longation of the action potential in a concentration-dependent
manner (Calloe et al., 2009a). Moreover, large increases in I to to a
point where CaV1.2 fails to activate, action potentials show a dra-
matic shortening (Greenstein et al., 2000; Sah et al., 2003; Calloe
et al., 2011). Selective pharmacological inhibition of I to,f in species
with a spike-and-dome morphology action potential is yet to be
studied.
In rodents, I to is part of the terminal repolarization and action
potential prolongation is consistently seen in the absence of the
current (Nerbonne et al., 2001). This action potential prolon-
gation elevates cytosolic calcium levels and improves excitation–
contraction coupling by mechanisms distinct from the effects of
I to modulation in largermammals (Sah et al., 2003). Furthermore,
an elevated calcium level activates the calcium-sensitive phos-
phatase calcineurin and initiates hypertrophic signaling (Kassiri
et al., 2002; Zobel et al., 2002; Lebeche et al., 2004). Transcriptional
regulation of many hypertrophic genes is regulated via NFAT by
the activity of calcineurin (Gaughan et al., 1998; Zobel et al., 2002;
Gong et al., 2006; Jin et al., 2010). It appears that an increased
cytosolic calcium concentration during adrenergically induced
hypercontractility activates calcineurin initiating the hypertrophic
response. Hypertrophy is not observed in models with geneti-
cally reduced I to,f in the absence of action potential prolongation,
potentially due to chronic upregulation of other repolarizing cur-
rents (Kuo et al., 2001; Guo et al., 2005). Interestingly, concentric
hypertrophy inWT mice secondary to aortic banding is associated
with prolonged action potentials, decreased I to,f and an increased
protein level of the ion channel underlying IK,slow1 (Marionneau
et al., 2008), whereas angiotensin-II mediated hypertension caus-
ing cardiac hypertrophy leaves I to,f density and KV4.2, KV4.3, and
KChIP2 protein contents unaltered.
Using KChIP2 overexpression to successfully prevent hyper-
trophy in rats showed that a KChIP2-mediated upregulation of
I to shortened action potentials and reduced myocardial shorten-
ing (Jin et al., 2010). In the same study, the authors showed that
KChIP2 overexpression decreased calcineurin expression in vitro,
suggesting that action potential shortening abrogates the hyper-
trophic response via the calcineurin pathway. Moreover, simulta-
neous overexpression of KV4.3 and induction of concentric hyper-
trophy in rat hearts showeda robust increase in I to, actionpotential
abbreviation, reduced calcineurin expression and an attenuated
hypertrophic response (Lebeche et al., 2004).
Transgenicmice overexpressing calcineurin have a reduced I to,f ,
prolonged action potential duration and display cardiac hypertro-
phy, which could all be reversed by pharmacological inhibition of
calcineurin (Dong et al.,2003,2010). In youngmiceoverexpressing
calcineurin, a paradoxical increased I to,f was measured, secondary
to elevated KV4.2 expression (Gong et al., 2006). It was hypothe-
sized that two regulatory pathways operated inparallel,one leading
to positive regulation of KV4.2 transcription via activation of cal-
cineurin and NFAT translocation (Gong et al., 2006); and one that
via NF-κB phosphorylation reduces I to,f via downregulation of
KChIP2 and KV4.3 (Panama et al., 2011).
HEART FAILURE
Heart failure is the condition, where the ability of the heart to
adequately supply blood ﬂow to meet the demand of the body
is impaired. Whereas the underlying index events are often man-
ageable if identiﬁed early, treatment options for heart failure are
mainly palliative or merely slowing the relentless progression of
symptoms (Dickstein et al., 2008). At end-stage heart failure, ther-
apeutic options are heart transplantation or mechanical support
devices. The lifetime risk of acquiring heart failure is estimated to
20% (Lloyd-Jones et al., 2002) and the 5-year mortality rate after
diagnosis is 50% (Stewart et al., 2001).
Functional reduction of I to has been observed in many ani-
mal models of heart failure (Nass et al., 2008) in addition to
human samples from terminal heart failure transplants (Beuckel-
mann et al., 1993;Wettwer et al., 1994; Nabauer et al., 1996). KV4.3
mRNA is reduced in human (Kaab et al., 1998) and canine heart
failure (Akar et al., 2005). KChIP2 mRNA and protein is down-
regulated in human heart failure (Radicke et al., 2006; Soltysinska
et al., 2009), although reports of unchanged KChIP2 levels are also
available (Zicha et al., 2004). Heart failure secondary to pressure
overload reduces peak potassium currents in mice, but does not
completely abolish I to,f (Wang et al., 2007; Grubb et al., 2011).
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Furthermore, preliminary studies show a reduction of non-I to,f
currents in KChIP2−/− mice with heart failure, adding another
layer of complexity to the electrophysiological remodeling seen in
heart failure (Grubb et al., 2011).
LIMITATIONS
In order to translate ﬁndings in experimental models to useful
information in a clinical setting, a clear understanding of species
dependent differences is electrophysiology of rodents and larger
mammals is imperative. Compatible with having a higher heart
rate than larger mammals, rodents have a much shorter action
potential and I to is involved with total repolarization, whereas it
constitutes the notch between the spike-and-dome in the action
potential of largermammals (for review,seeNerbonne et al.,2001).
In rodents, a loss of I to leads to a prolonged APD which results
in a loss of temporal synchronization of the Ca2+ entry through
ICa,L due to channel inactivation instead of deactivation causing a
longer Ca2+ entry and a stronger but less synchronized SR Ca2+
release. In larger mammals, instead of being responsible for ICa,L
deactivation, I to provides a driving force for Ca2+ entry, and a
decreased I to therefore leads to an ICa,L reduction andadesynchro-
nized intracellular Ca2+-transient (for review, see Sah et al., 2003).
This is an important species dependent difference, and should be
considered when using rodents as a model of hypertrophy or heart
failure. Moreover, extrapolation of physiological data from rodent
studies to clinical practice should always be performed with out-
most caution and only with supporting results from additional
experimental models and human trials.
The KChIP2−/− mouse does not show any apparent pathol-
ogy; however, it is not uncommon that knockout animals lack
phenotypic changes which may be due to a redundancy of genes
that can compensate for the reduced repolarization reserve. The
KChIP2−/− mouse is not an organ-speciﬁc knockout, which may
have unspeciﬁc, peripheral effects compared to a cardiac-speciﬁc
knockout mice, since many genes are expressed in several organs,
including KChIP2 (An et al., 2000). Furthermore, the knockout
of KChIP2 is congenital and non-inducible, which means that
remodeling in the knockout animal could happen during develop-
ment. This could be avoided by using an inducible organ-speciﬁc
knockout or a tissue speciﬁc gene transfer by viral infection,which
would also be preferable for studying the remodeling in hyper-
trophy or heart failure, since no pre-existing remodeling would
exist.
SUMMARY AND CONCLUDING REMARKS
Substantial progress has been made in the mapping of the mul-
tiple characteristics and roles of KChIP2 in the heart. KChIP2
have been reported to modulate KV1.5, KV4.2, KV4.3, CaV1.2,
and NaV1.5. Both KV4.2 and KV4.3 are intimately regulated by
KChIP2, where peak current is increased, inactivation kinetics are
slowed and recovery from inactivation is accelerated by the pres-
ence of KChIP2 (An et al., 2000). CaV1.2-conducted current is
increased by KChIP2 via a potential interaction at the amino-
terminal inhibitory module on the α1C subunit of the L-type
Ca2+ channel (Thomsen et al., 2009c). Conﬂicting reports regard-
ing KChIP2-mediated modulation of KV1.5 and NaV1.5 exists
and points toward areas where intensiﬁed research is required to
resolve discrepancies and clarify ourunderstandingof cardiac elec-
trophysiology. Cardiac memory, hypertrophy, and failure are all
associated with reductions in KChIP2 and it appears that overex-
pression of KChIP2 can prevent the development of hypertrophy
in rats (Jin et al., 2010).
Several aspects remains poorly understood, however. Given
the promiscuity of KChIP2, it is possible that additional bind-
ing partners will be identiﬁed, potentially in non-cardiac tissue.
The physiological relevance of the many individual interactions
needs to be tested and compared in health and disease. The ﬁnding
that KChIP2 overexpression can prevent the development of the
hypertrophic response may have implications for future clinical
approaches to heart disease, although extrapolation from rodent
to patient should be donewith outmost caution. Excessive KChIP2
overexpression increasing I to may in spite of an augmented inward
ICa,L lead to an early repolarization in mammals associated with
a Brugada-like phenotype (Calloe et al., 2009a). Presently it is
unknown whether KChIP2 holds regulatory control in the devel-
opment of heart failure similar to its central role in the progress
of cardiac hypertrophy. Furthermore, the antiarrhythmic prop-
erties of KChIP2 are still ill described, notwithstanding its initial
report (Kuo et al., 2001). Reduced KChIP2 levels confer smaller
ICa,L potentially reducing the amplitude of early afterdepolariza-
tions in events of current reactivation at long action potentials,
reducing the risk of triggering ventricular arrhythmias. How-
ever, optimal KChIP2 levels contribute to maintaining minimal
regional repolarization dispersion, thus reducing the substrate for
arrhythmias. Nonetheless, KChIP2 is a multipronged modiﬁer of
a series of voltage-gated cardiac ion channels and has important
physiological functions in health and in heart disease.
ACKNOWLEDGMENTS
This work was supported by grants from the Danish Agency for
Science, Technology and Innovation, Medical Research Coun-
cil (to Morten B. Thomsen) and from the Danish National
Research Foundation Centre for Cardiac Arrhythmia (to Kirstine
Calloe).
REFERENCES
Aiba, T., and Tomaselli, G. F. (2010).
Electrical remodeling in the failing
heart.Curr. Opin. Cardiol. 25, 29–36.
Akar, F. G., Wu, R. C., Juang, G. J.,
Tian, Y., Burysek, M., Disilvestre,
D., Xiong, W., Armoundas, A. A.,
and Tomaselli, G. F. (2005). Mol-
ecular mechanisms underlying K+
current downregulation in canine
tachycardia-induced heart failure.
Am. J. Physiol. Heart Circ. Physiol.
288, H2887–H2896.
An,W. F., Bowlby, M. R., Betty, M., Cao,
J., Ling, H. P., Mendoza, G., Hin-
son, J.W.,Mattsson, K. I., Strassle, B.
W., Trimmer, J. S., and Rhodes, K. J.
(2000).Modulation of A-type potas-
sium channels by a family of calcium
sensors. Nature 403, 553–556.
Anderson, D., Mehaffey, W. H., Ift-
inca, M., Rehak, R., Engbers, J.
D., Hameed, S., Zamponi, G.
W., and Turner, R. W. (2010).
Regulation of neuronal activity
by Cav3–Kv4 channel signaling
complexes. Nat. Neurosci. 13,
333–337.
Bahring, R., Dannenberg, J., Peters,
H. C., Leicher, T., Pongs, O.,
and Isbrandt, D. (2001). Conserved
Kv4 N-terminal domain critical for
effects of Kv channel-interacting
protein 2.2 on channel expression
and gating. J. Biol. Chem. 276,
23888–23894.
Barry, D. M., Xu, H., Schuessler, R.
B., and Nerbonne, J. M. (1998).
Functional knockout of the tran-
sient outward current, long-QT
syndrome, and cardiac remodeling
in mice expressing a dominant-
negativeKv4 alpha subunit.Circ. Res.
83, 560–567.
Frontiers in Physiology | Cardiac Electrophysiology May 2012 | Volume 3 | Article 118 | 6
Grubb et al. KChIP2 and cardiac electrophysiology
Beuckelmann, D. J., Nabauer, M., and
Erdmann, E. (1993). Alterations of
K+ currents in isolated human ven-
tricular myocytes from patients with
terminal heart failure. Circ. Res. 73,
379–385.
Brouillette, J., Clark, R. B., Giles, W.
R., and Fiset, C. (2004). Functional
properties of K+ currents in adult
mouse ventricularmyocytes. J. Phys-
iol. (Lond.) 559, 777–798.
Brunet, S., Aimond, F., Li, H., Guo,
W., Eldstrom, J., Fedida, D., Yamada,
K. A., and Nerbonne, J. M. (2004).
Heterogeneous expression of repo-
larizing, voltage-gated K+ currents
in adult mouse ventricles. J. Physiol.
(Lond.) 559, 103–120.
Burgoyne, R. D., and Weiss, J. L. (2001).
The neuronal calcium sensor family
of Ca2+-binding proteins. Biochem.
J. 353, 1–12.
Buxbaum, J. D. (2004). A role for calse-
nilin and related proteins in mul-
tiple aspects of neuronal function.
Biochem. Biophys. Res. Commun.
322, 1140–1144.
Calloe, K., Cordeiro, J. M., Di Diego,
J. M., Hansen, R. S., Grunnet, M.,
Olesen, S. P., and Antzelevitch, C.
(2009a). A transient outward potas-
sium current activator recapitulates
the electrocardiographic manifesta-
tions of Brugada syndrome. Cardio-
vasc. Res. 81, 686–694.
Calloe, K., Soltysinska, E., Jespersen, T.,
Lundby, A., Antzelevitch, C., Ole-
sen, S. P., and Cordeiro, J. M.
(2009b). Differential effects of the
transient outward K+ current acti-
vator NS5806 in the canine left
ventricle. J. Mol. Cell. Cardiol. 48,
191–200.
Calloe, K., Nof, E., Jespersen, T., Di
Diego, J. M., Chlus, N., Olesen, S.
P., Antzelevitch, C., and Cordeiro,
J. M. (2011). Comparison of the
effects of a transient outward
potassium channel activator on
currents recorded from atrial
and ventricular cardiomyocytes.
J. Cardiovasc. Electrophysiol. 22,
1057–1066.
Carmeliet, E. (1999). Cardiac ionic cur-
rents and acute ischemia: fromchan-
nels to arrhythmias. Physiol. Rev. 79,
917–1017.
Cordeiro, J. M., Greene, L., Heilmann,
C., Antzelevitch, D., and Antzele-
vitch, C. (2004). Transmural het-
erogeneity of calcium activity and
mechanical function in the canine
left ventricle. Am. J. Physiol. Heart
Circ. Physiol. 286, H1471–H1479.
Decher, N., Uyguner, O., Scherer, C.
R., Karaman, B., Yuksel-Apak, M.,
Busch, A. E., Steinmeyer, K., and
Wollnik, B. (2001). HKChIP2 is a
functionalmodiﬁer of hKv4.3 potas-
sium channels: cloning and expres-
sion of a short hKChIP2 splice vari-
ant. Cardiovasc. Res. 52, 255–264.
Deschenes, I., Armoundas, A. A., Jones,
S. P., and Tomaselli, G. F. (2008).
Post-transcriptional gene silencing
of KChIP2 andNavbeta1 in neonatal
rat cardiac myocytes reveals a func-
tional association between Na and
Ito currents. J. Mol. Cell. Cardiol. 45,
336–346.
Deschenes, I., Disilvestre, D., Juang, G.
J.,Wu,R. C.,An,W. F., andTomaselli,
G. F. (2002). Regulation of Kv4.3
current by KChIP2 splice variants: a
component of native cardiac I(to)?
Circulation 106, 423–429.
DeSimone, C. V., Zarayskiy, V. V., Bon-
darenko, V. E., and Morales, M. J.
(2011). Heteropoda toxin 2 interac-
tionwithKv4.3 andKv4.1 reveals dif-
ferences in gatingmodiﬁcation. Mol.
Pharmacol. 80, 345–355.
Dickstein, K., Cohen-Solal, A., Fil-
ippatos, G., Mcmurray, J. J.,
Ponikowski, P., Poole-Wilson, P. A.,
Stromberg, A., Van Veldhuisen, D.
J., Atar, D., Hoes, A. W., Keren, A.,
Mebazaa, A., Nieminen, M., Priori,
S. G., Swedberg, K., Vahanian, A.,
Camm, J., De Caterina, R., Dean,
V., Funck-Brentano, C., Hellemans,
I., Kristensen, S. D., Mcgregor, K.,
Sechtem, U., Silber, S., Tendera,
M., Widimsky, P., and Zamorano,
J. L. (2008). ESC guidelines for the
diagnosis and treatment of acute
and chronic heart failure 2008: the
Task Force for the Diagnosis and
Treatment of Acute and Chronic
Heart Failure 2008 of the European
Society of Cardiology. Developed in
collaboration with the Heart Failure
Association of the ESC (HFA) and
endorsed by the European Society of
Intensive Care Medicine (ESICM).
Eur. Heart J. 29, 2388–2442.
Dong,D.,Duan,Y., Guo, J., Roach,D. E.,
Swirp, S. L., Wang, L., Lees-Miller, J.
P., Sheldon, R. S., Molkentin, J. D.,
and Duff, H. J. (2003). Overexpres-
sion of calcineurin in mouse causes
sudden cardiac death associatedwith
decreased density of K+ channels.
Cardiovasc. Res. 57, 320–332.
Dong, M., Yan, S., Chen, Y., Niklewski,
P. J., Sun, X., Chenault, K., and
Wang, H. S. (2010). Role of the
transient outward current in regulat-
ing mechanical properties of canine
ventricular myocytes. J. Cardiovasc.
Electrophysiol. 21, 697–703.
Doronin, S. V., Potapova, I. A., Lu, Z. J.,
and Cohen, I. S. (2004). Angiotensin
receptor type 1 forms a complex
with the transient outward potas-
sium channel Kv4.3 and regulates
its gating properties and intracellu-
lar localization. J. Biol. Chem. 279,
48231–48237.
Foeger, N. C.,Marionneau, C., and Ner-
bonne, J. M. (2010). Co-assembly
of Kv4 {alpha} subunits with K+
channel-interacting protein 2 sta-
bilizes protein expression and pro-
motes surface retention of chan-
nel complexes. J. Biol. Chem. 285,
33413–33422.
Gaborit, N., Le Bouter, S., Szuts, V.,
Varro, A., Escande, D., Nattel, S., and
Demolombe, S. (2007). Regional
and tissue speciﬁc transcript signa-
tures of ion channel genes in the
non-diseased human heart. J. Phys-
iol. (Lond.) 582, 675–693.
Gaughan, J. P., Hefner, C. A., and
Houser, S. R. (1998). Electro-
physiological properties of neona-
tal rat ventricular myocytes with
alpha1-adrenergic-induced hyper-
trophy. Am. J. Physiol. 275, H577–
H590.
Gong,N. L.,Bodi, I.,Zobel,C.,Schwartz,
A., Molkentin, J. D., and Backx, P.
H. (2006). Calcineurin increases car-
diac transient outward K+ currents
via transcriptional up-regulation of
Kv4.2 channel subunits. J. Biol.
Chem. 281, 38498–38506.
Greenstein, J. L., Wu, R., Po, S.,
Tomaselli, G. F., and Winslow, R.
L. (2000). Role of the calcium-
independent transient outward cur-
rent I(to1) in shaping action poten-
tial morphology and duration. Circ.
Res. 87, 1026–1033.
Grubb, S., Speerschneider, T., Olesen, S.
P., Thomsen, M. B., and Calloe, K.
(2011). Reduction of potassium cur-
rents in heart failure is accentuated
in K+ channel interacting protein
2 deﬁcient mice. Heart Rhythm 8,
S459.
Guo, W., Jung, W. E., Marionneau,
C., Aimond, F., Xu, H., Yamada, K.
A., Schwarz, T. L., Demolombe, S.,
and Nerbonne, J. M. (2005). Tar-
geted deletion of Kv4.2 eliminates
I(to,f) and results in electrical and
molecular remodeling, with no evi-
dence of ventricular hypertrophy or
myocardial dysfunction. Circ. Res.
97, 1342–1350.
Guo, W., Xu, H., London, B., and
Nerbonne, J. M. (1999). Molecular
basis of transient outward K+ cur-
rent diversity in mouse ventricular
myocytes. J. Physiol. (Lond.) 521(Pt
3), 587–599.
Guo,W. N., Li, H. L., Aimond, F., Johns,
D. C., Rhodes, K. J., Trimmer, J. S.,
and Nerbonne, J. M. (2002). Role of
heteromultimers in the generation
of myocardial transient outward K+
currents. Circ. Res. 90, 586–593.
Harris, D. M., Mills, G. D., Chen,
X., Kubo, H., Berretta, R. M.,
Votaw, V. S., Santana, L. F., and
Houser, S. R. (2005). Alterations in
early action potential repolarization
causes localized failure of sarcoplas-
mic reticulum Ca2+ release. Circ.
Res. 96, 543–550.
Himmel, H. M., Wettwer, E., Li, Q.,
andRavens,U. (1999). Fourdifferent
components contribute to outward
current in rat ventricular myocytes.
Am. J. Physiol. 277, H107–H118.
Holmqvist, M. H., Cao, J., Hernandez-
Pineda, R., Jacobson, M. D., Car-
roll, K. I., Sung, M. A., Betty, M.,
Ge, P., Gilbride, K. J., Brown, M. E.,
Jurman, M. E., Lawson, D., Silos-
Santiago, I., Xie, Y., Covarrubias, M.,
Rhodes, K. J., Distefano, P. S., and
An, W. F. (2002). Elimination of fast
inactivation in Kv4 A-type potas-
sium channels by an auxiliary sub-
unit domain. Proc. Natl. Acad. Sci.
U.S.A. 99, 1035–1040.
Jin, H., Hadri, L., Palomeque, J., Morel,
C., Karakikes, I., Kaprielian, R., Haj-
jar, R., and Lebeche, D. (2010).
KChIP2 attenuates cardiac hyper-
trophy through regulation of Ito
and intracellular calcium signaling.
J. Mol. Cell. Cardiol. 48, 1169–1179.
Kaab, S., Dixon, J., Duc, J., Ashen, D.,
Nabauer, M., Beuckelmann, D. J.,
Steinbeck, G., Mckinnon, D., and
Tomaselli, G. F. (1998). Molecular
basis of transient outwardpotassium
current downregulation in human
heart failure: a decrease in Kv4.3
mRNA correlates with a reduction
in current density. Circulation 98,
1383–1393.
Kassiri, Z., Zobel, C., Nguyen, T. T.,
Molkentin, J. D., and Backx, P. H.
(2002). Reduction of I(to) causes
hypertrophy in neonatal rat ven-
tricular myocytes. Circ. Res. 90,
578–585.
Kim, L. A., Furst, J., Butler, M. H., Xu,
S. H., Grigorieff, N., and Goldstein,
S. A. N. (2004). I-to channels are
octomeric complexes with four sub-
units of each Kv4.2 and K+ channel-
interacting protein 2. J. Biol. Chem.
279, 5549–5554.
Kuo, H. C., Cheng, C. F., Clark, R. B.,
Lin, J. J., Lin, J. L., Hoshijima, M.,
Nguyen-Tran, V. T., Gu, Y., Ikeda,
Y., Chu, P. H., Ross, J., Giles, W. R.,
and Chien, K. R. (2001). A defect in
the Kv channel-interacting protein 2
(KChIP2) gene leads to a complete
loss of I(to) and confers suscepti-
bility to ventricular tachycardia. Cell
107, 801–813.
Lebeche, D., Kaprielian, R., Del Monte,
F., Tomaselli, G., Gwathmey, J. K.,
Schwartz,A., andHajjar, R. J. (2004).
www.frontiersin.org May 2012 | Volume 3 | Article 118 | 7
Grubb et al. KChIP2 and cardiac electrophysiology
In vivo cardiac gene transfer of Kv4.3
abrogates the hypertrophic response
in rats after aortic stenosis. Circula-
tion 110, 3435–3443.
Li, H. L., Guo, W. N., Mellor, R. L.,
and Nerbonne, J. M. (2005). KChIP2
modulates the cell surface expression
of Kv1.5-encoded K+ channels. J.
Mol. Cell. Cardiol. 39, 121–132.
Liu, J., Kim, K. H., London, B.,
Morales, M. J., and Backx, P. H.
(2011). Dissection of the voltage-
activated potassium outward cur-
rents in adult mouse ventricular
myocytes: I(to,f), I(to,s), I(K,slow1),
I(K,slow2), and I(ss). Basic Res. Car-
diol. 106, 189–204.
Lloyd-Jones, D. M., Larson, M. G., Leip,
E. P., Beiser, A., D’Agostino, R. B.,
Kannel,W.B.,Murabito, J.M.,Vasan,
R. S., Benjamin, E. J., and Levy,
D. (2002). Lifetime risk for devel-
oping congestive heart failure: the
Framingham Heart Study. Circula-
tion 106, 3068–3072.
London, B.,Wang, D. W., Hill, J. A., and
Bennett, P. B. (1998). The transient
outward current in mice lacking the
potassium channel gene Kv1.4. J.
Physiol. 509(Pt 1), 171–182.
Lundby, A., Jespersen, T., Schmitt, N.,
Grunnet, M., Olesen, S. P., Cordeiro,
J. M., and Calloe, K. (2010). Effect
of the I(to) activator NS5806 on
cloned K(v)4 channels depends on
the accessory protein KChIP2. Br. J.
Pharmacol. 160, 2028–2044.
Lundby, A., and Olesen, S. P. (2006).
KCNE3 is an inhibitory subunit
of the Kv4.3 potassium channel.
Biochem. Biophys. Res. Commun.
346, 958–967.
Marionneau, C., Brunet, S., Flagg, T.
P., Pilgram, T. K., Demolombe, S.,
andNerbonne, J.M. (2008). Distinct
cellular and molecular mechanisms
underlie functional remodeling of
repolarizing K+ currents with left
ventricular hypertrophy. Circ. Res.
102, 1406–1415.
Nabauer, M., Beuckelmann, D. J.,
Uberfuhr, P., and Steinbeck, G.
(1996). Regional differences in
current density and rate-dependent
properties of the transient out-
ward current in subepicardial
and subendocardial myocytes of
human left ventricle. Circulation 93,
168–177.
Nass,R. D.,Aiba,T.,Tomaselli,G. F., and
Akar, F. G. (2008). Mechanisms of
disease: ion channel remodeling in
the failing ventricle. Nat. Clin. Pract.
Cardiovasc. Med. 5, 196–207.
Nattel, S., Maguy, A., Le Bouter, S., and
Yeh, Y. H. (2007). Arrhythmogenic
ion-channel remodeling in the heart:
heart failure, myocardial infarction,
and atrial ﬁbrillation. Physiol. Rev.
87, 425–456.
Nerbonne, J. M., and Kass, R. S.
(2005). Molecular physiology of car-
diac repolarization. Physiol. Rev. 85,
1205–1253.
Nerbonne, J. M., Nichols, C. G.,
Schwarz, T. L., and Escande, D.
(2001). Genetic manipulation of
cardiac K+ channel function in
mice: what have we learned, and
where do we go from here? Circ. Res.
89, 944–956.
Ozgen, N., Lau, D. H., Shlapakova, I. N.,
Sherman,W., Feinmark, S. J.,Danilo,
P. Jr., and Rosen, M. R. (2010).
Determinants of CREB degradation
and KChIP2 gene transcription in
cardiac memory. Heart Rhythm 7,
964–970.
Panama, B. K., Latour-Villamil, D., Far-
man, G. P., Zhao, D., Bolz, S. S.,
Kirshenbaum, L. A., and Backx,
P. H. (2011). Nuclear factor kap-
paB downregulates the transient
outward potassium current I(to,f)
through control of KChIP2 expres-
sion. Circ. Res. 108, 537–543.
Patberg, K. W., Obreztchikova, M. N.,
Giardina, S. F., Symes, A. J., Plot-
nikov, A. N., Qu, J. H., Chandra, P.,
Mckinnon, D., Liou, S. R., Rybin, A.
V., Shlapakova, I., Danilo, P., Yang, J.,
and Rosen, M. R. (2005). The cAMP
response element binding protein
modulates expression of the tran-
sient outward current: implications
for cardiac memory. Cardiovasc. Res.
68, 259–267.
Patberg, K. W., Plotnikov, A. N., Quam-
ina, A., Gainullin, R. Z., Rybin,
A., Danilo, P. Jr., Sun, L. S., and
Rosen, M. R. (2003). Cardiac mem-
ory is associated with decreased
levels of the transcriptional factor
CREB modulated by angiotensin II
and calcium. Circ. Res. 93, 472–478.
Patel, S. P., and Campbell, D. L. (2005).
Transient outward potassium cur-
rent, ‘I-to’, phenotypes in the mam-
malian left ventricle: underlying
molecular, cellular and biophysical
mechanisms. J. Physiol. (Lond.) 569,
7–39.
Patel, S. P., Campbell, D. L., and Strauss,
H. C. (2002). Elucidating KChIP
effects on Kv4.3 inactivation and
recovery kinetics with a minimal
KChIP2 isoform. J. Physiol. (Lond.)
545, 5–11.
Pioletti, M., Findeisen, F., Hura, G.
L., and Minor, D. L. (2006).
Three-dimensional structure of the
KChIP1–Kv4.3 T1 complex reveals
a cross-shaped octamer. Nat. Struct.
Mol. Biol. 13, 987–995.
Plotnikov, A. N., Sosunov, E. A., Pat-
berg, K. W., Anyukhovsky, E. P.,
Gainullin, R. Z., Shlapakova, I. N.,
Krishnamurthy,G.,Danilo,P. Jr., and
Rosen, M. R. (2004). Cardiac mem-
ory evolves with age in association
with development of the transient
outward current. Circulation 110,
489–495.
Plotnikov, A. N., Yu, H., Geller, J. C.,
Gainullin, R. Z., Chandra, P., Pat-
berg, K. W., Friezema, S., Danilo, P.
Jr., Cohen, I. S., Feinmark, S. J., and
Rosen, M. R. (2003). Role of L-type
calcium channels in pacing-induced
short-term and long-term cardiac
memory in canine heart. Circulation
107, 2844–2849.
Radicke, S., Cotella, D., Graf, E. M.,
Banse, U., Jost, N., Varro, A., Tseng,
G. N., Ravens, U., and Wettwer, E.
(2006). Functional modulation of
the transient outward current Ito
byKCNEbeta-subunits and regional
distribution in human non-failing
and failing hearts. Cardiovasc. Res.
71, 695–703.
Radicke, S., Cotella, D., Graf, E.
M., Ravens, U., and Wettwer, E.
(2005). Expression and function
of dipeptidyl-aminopeptidase-like
protein 6 as a putative beta-subunit
of human cardiac transient outward
current encoded by Kv4.3. J. Physiol.
(Lond.) 565, 751–756.
Rosati, B., Grau, F., Rodriguez, S., Li,
H. L., Nerbonne, J. M., and Mckin-
non, D. (2003). Concordant expres-
sion of KChIP2 mRNA, protein and
transient outward current through-
out the canine ventricle. J. Physiol.
(Lond.) 548, 815–822.
Rosati, B., Pan, Z. M., Lypen, S., Wang,
H. S., Cohen, I., Dixon, J. E., and
Mckinnon, D. (2001). Regulation
of KChIP2 potassium channel beta
subunit gene expression underlies
the gradient of transient outward
current in canine and human ventri-
cle. J. Physiol. (Lond.) 533, 119–125.
Rosen, M. R. (2001). The heart remem-
bers: clinical implications. Lancet
357, 468–471.
Rosen, M. R., and Cohen, I. S. (2006).
Cardiac memory... new insights into
molecular mechanisms. J. Physiol.
570, 209–218.
Rosenbaum, M. B., Blanco, H. H.,
Elizari, M. V., Lazzari, J. O., and
Davidenko, J. M. (1982). Electro-
tonic modulation of the T wave and
cardiac memory. Am. J. Cardiol. 50,
213–222.
Sadoshima, J., and Izumo, S. (1993).
Molecular characterization of
angiotensin II-induced hypertrophy
of cardiac myocytes and hyperplasia
of cardiac ﬁbroblasts. Critical role
of the AT1 receptor subtype. Circ.
Res. 73, 413–423.
Sah, R., Ramirez, R. J., and Backx, P.
H. (2002). Modulation of Ca(2+)
release in cardiac myocytes by
changes in repolarization rate: role
of phase-1 action potential repo-
larization in excitation–contraction
coupling. Circ. Res. 90, 165–173.
Sah, R., Ramirez, R. J., Oudit, G.
Y., Gidrewicz, D., Trivieri, M. G.,
Zobel, C., and Backx, P. H. (2003).
Regulation of cardiac excitation–
contraction coupling by action
potential repolarization: role of the
transient outward potassium cur-
rent (I(to)). J. Physiol. (Lond.) 546,
5–18.
Sanguinetti,M. C., Johnson, J. H.,Ham-
merland, L. G.,Kelbaugh,P. R.,Volk-
mann, R. A., Saccomano, N. A., and
Mueller, A. L. (1997). Heteropoda-
toxins: peptides isolated from spi-
der venom that block Kv4.2 potas-
sium channels. Mol. Pharmacol. 51,
491–498.
Soltysinska, E., Olesen, S. P., Christ,
T., Wettwer, E., Varro, A., Grunnet,
M., and Jespersen, T. (2009). Trans-
mural expression of ion channels
and transporters in human nondis-
eased and end-stage failing hearts.
Pﬂügers Arch. 459, 11–23.
Stewart, S., Macintyre, K., Hole, D. J.,
Capewell, S., and Mcmurray, J. J.
(2001). More ‘malignant’ than can-
cer? Five-year survival following a
ﬁrst admission for heart failure. Eur.
J. Heart Fail. 3, 315–322.
Takimoto, K., Yang, E. K., and Con-
forti, L. (2002). Palmitoylation of
KChIP splicing variants is required
for efﬁcient cell surface expression
of Kv4.3 channels. J. Biol. Chem. 277,
26904–26911.
Ter Keurs, H. E., and Boyden, P. A.
(2007). Calcium and arrhythmoge-
nesis. Physiol. Rev. 87, 457–506.
Teutsch, C., Kondo, R. P., Dederko, D.
A., Chrast, J., Chien, K. R., and Giles,
W. R. (2007). Spatial distributions of
Kv4 channels and KChip2 isoforms
in the murine heart based on laser
capturemicrodissection.Cardiovasc.
Res. 73, 739–749.
Thomsen, M. B., Foster, E., Nguyen,
K. H., and Sosunov, E. A. (2009a).
Transcriptional and electrophysio-
logical consequences of KChIP2-
mediated regulation of CaV1.2.
Channels (Austin) 3, 308–310.
Thomsen, M. B., Sosunov, E. A.,
Anyukhovsky, E. P., Özgen, N., Boy-
den, P. A., and Rosen, M. R.
(2009b). Deleting the accessory sub-
unit KChIP2 results in loss of
Ito,f and increased IK,slow that
maintains normal action poten-
tial conﬁguration. Heart Rhythm 6,
370–377.
Frontiers in Physiology | Cardiac Electrophysiology May 2012 | Volume 3 | Article 118 | 8
Grubb et al. KChIP2 and cardiac electrophysiology
Thomsen, M. B., Wang, C., Ozgen, N.,
Wang, H. G., Rosen, M. R., and
Pitt, G. S. (2009c). Accessory sub-
unit KChIP2 modulates the cardiac
L-type calcium current. Circ. Res.
104, 1382–1389.
Wang,Y. G., Cheng, J., Chen,G. H., Rob,
F., Naseem, R. H., Nguyen, L., John-
stone, J. L., and Hill, J. A. (2007).
Remodeling of outward K+ cur-
rents in pressure-overload heart fail-
ure. J. Cardiovasc. Electrophysiol. 18,
869–875.
Wasserstrom, J. A., Sharma, R., Kapur,
S., Kelly, J. E., Kadish, A. H.,
Balke, C. W., and Aistrup, G. L.
(2009). Multiple defects in intracel-
lular calcium cycling in whole fail-
ing rat heart. Circ. Heart Fail 2,
223–232.
Wettwer, E.,Amos,G. J., Posival,H., and
Ravens, U. (1994). Transient out-
ward current in human ventricu-
lar myocytes of subepicardial and
subendocardial origin. Circ. Res. 75,
473–482.
Wickenden,A. D., Jegla, T. J., Kaprielian,
R., and Backx, P. H. (1999a).
Regional contributions of Kv1.4,
Kv4.2, and Kv4.3 to transient out-
ward K+ current in rat ventricle.
Am. J. Physiol. 276, H1599–H1607.
Wickenden, A. D., Lee, P., Sah, R.,
Huang, Q., Fishman, G. I., and
Backx, P. H. (1999b). Targeted
expression of a dominant-negative
K(v)4.2 K+ channel subunit in
the mouse heart. Circ. Res. 85,
1067–1076.
Yu, H., Mckinnon, D., Dixon, J. E., Gao,
J., Wymore, R., Cohen, I. S., Danilo,
P. Jr., Shvilkin,A.,Anyukhovsky,E. P.,
Sosunov, E. A., Hara, M., and Rosen,
M. R. (1999). Transient outward
current, Ito1, is altered in cardiac
memory. Circulation 99, 1898–1905.
Zhang, M., Jiang, M., and Tseng, G.
N. (2001). minK-related peptide 1
associates with Kv4.2 and modu-
lates its gating function: potential
role as beta subunit of cardiac tran-
sient outward channel? Circ. Res. 88,
1012–1019.
Zicha, S., Xiao, L., Stafford, S., Cha,
T. J., Han, W., Varro, A., and
Nattel, S. (2004). Transmural
expression of transient outward
potassium current subunits in
normal and failing canine and
human hearts. J. Physiol. 561(Pt 3),
735–748.
Zobel, C., Kassiri, Z., Nguyen, T. T.,
Meng, Y., and Backx, P. H. (2002).
Prevention of hypertrophy by over-
expression of Kv4.2 in cultured
neonatal cardiomyocytes. Circula-
tion 106, 2385–2391.
Conﬂict of Interest Statement: The
authors declare that the research was
conducted in the absence of any
commercial or ﬁnancial relationships
that could be construed as a potential
conﬂict of interest.
Received: 27 February 2012; paper pend-
ing published: 03 April 2012; accepted:
11 April 2012; published online: 04 May
2012.
Citation: Grubb S, Calloe K and Thom-
sen MB (2012) Impact of KChIP2 on
cardiac electrophysiology and the progres-
sion of heart failure. Front. Physio. 3:118.
doi: 10.3389/fphys.2012.00118
This article was submitted to Frontiers in
Cardiac Electrophysiology, a specialty of
Frontiers in Physiology.
Copyright © 2012 Grubb, Calloe and
Thomsen. This is an open-access arti-
cle distributed under the terms of
the Creative Commons Attribution Non
Commercial License, which permits non-
commercial use, distribution, and repro-
duction in other forums, provided the
original authors and source are credited.
www.frontiersin.org May 2012 | Volume 3 | Article 118 | 9
